393 related articles for article (PubMed ID: 36979908)
1. Mechanisms of COVID-19 Associated Pulmonary Thrombosis: A Narrative Review.
Niculae CM; Hristea A; Moroti R
Biomedicines; 2023 Mar; 11(3):. PubMed ID: 36979908
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of immunothrombosis in COVID-19.
Portier I; Campbell RA; Denorme F
Curr Opin Hematol; 2021 Nov; 28(6):445-453. PubMed ID: 34232139
[TBL] [Abstract][Full Text] [Related]
3. Venous thrombosis epidemiology, pathophysiology, and anticoagulant therapies and trials in severe acute respiratory syndrome coronavirus 2 infection.
Obi AT; Barnes GD; Napolitano LM; Henke PK; Wakefield TW
J Vasc Surg Venous Lymphat Disord; 2021 Jan; 9(1):23-35. PubMed ID: 32916371
[TBL] [Abstract][Full Text] [Related]
4. COVID-19, immunothrombosis and venous thromboembolism: biological mechanisms.
Loo J; Spittle DA; Newnham M
Thorax; 2021 Apr; 76(4):412-420. PubMed ID: 33408195
[TBL] [Abstract][Full Text] [Related]
5. The coagulopathy, endotheliopathy, and vasculitis of COVID-19.
Iba T; Connors JM; Levy JH
Inflamm Res; 2020 Dec; 69(12):1181-1189. PubMed ID: 32918567
[TBL] [Abstract][Full Text] [Related]
6. IL-1 induces throboxane-A2 (TxA2) in COVID-19 causing inflammation and micro-thrombi: inhibitory effect of the IL-1 receptor antagonist (IL-1Ra).
Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G; Toniato E
J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1623-1627. PubMed ID: 32744052
[TBL] [Abstract][Full Text] [Related]
7. Impaired coagulation, liver dysfunction and COVID-19: Discovering an intriguing relationship.
D'Ardes D; Boccatonda A; Cocco G; Fabiani S; Rossi I; Bucci M; Guagnano MT; Schiavone C; Cipollone F
World J Gastroenterol; 2022 Mar; 28(11):1102-1112. PubMed ID: 35431501
[TBL] [Abstract][Full Text] [Related]
8. COVID-19 and immunothrombosis: Pathophysiology and therapeutic implications.
Lim MS; Mcrae S
Crit Rev Oncol Hematol; 2021 Dec; 168():103529. PubMed ID: 34800652
[TBL] [Abstract][Full Text] [Related]
9. Platelets in the NETworks interweaving inflammation and thrombosis.
Wienkamp AK; Erpenbeck L; Rossaint J
Front Immunol; 2022; 13():953129. PubMed ID: 35979369
[TBL] [Abstract][Full Text] [Related]
10. Immunothrombotic Dysregulation in COVID-19 Pneumonia Is Associated With Respiratory Failure and Coagulopathy.
Nicolai L; Leunig A; Brambs S; Kaiser R; Weinberger T; Weigand M; Muenchhoff M; Hellmuth JC; Ledderose S; Schulz H; Scherer C; Rudelius M; Zoller M; Höchter D; Keppler O; Teupser D; Zwißler B; von Bergwelt-Baildon M; Kääb S; Massberg S; Pekayvaz K; Stark K
Circulation; 2020 Sep; 142(12):1176-1189. PubMed ID: 32755393
[TBL] [Abstract][Full Text] [Related]
11. The Impact of SARS-CoV-2 Infection on Blood Coagulation and Fibrinolytic Pathways: A Review of Prothrombotic Changes Caused by COVID-19.
Bahraini M; Dorgalaleh A
Semin Thromb Hemost; 2022 Feb; 48(1):19-30. PubMed ID: 34695858
[TBL] [Abstract][Full Text] [Related]
12. The pathogenesis of coronavirus-19 disease.
Borczuk AC; Yantiss RK
J Biomed Sci; 2022 Oct; 29(1):87. PubMed ID: 36289507
[TBL] [Abstract][Full Text] [Related]
13. Pathology of lung-specific thrombosis and inflammation in COVID-19.
Khismatullin RR; Ponomareva AA; Nagaswami C; Ivaeva RA; Montone KT; Weisel JW; Litvinov RI
J Thromb Haemost; 2021 Dec; 19(12):3062-3072. PubMed ID: 34538029
[TBL] [Abstract][Full Text] [Related]
14. Role of SARS-CoV-2 -induced cytokines and growth factors in coagulopathy and thromboembolism.
Ahmad F; Kannan M; Ansari AW
Cytokine Growth Factor Rev; 2022 Feb; 63():58-68. PubMed ID: 34750061
[TBL] [Abstract][Full Text] [Related]
15. Prothrombotic Phenotype in COVID-19: Focus on Platelets.
Barale C; Melchionda E; Morotti A; Russo I
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948438
[TBL] [Abstract][Full Text] [Related]
16. COVID-19 Sepsis: Pathogenesis and Endothelial Molecular Mechanisms Based on "Two-Path Unifying Theory" of Hemostasis and Endotheliopathy-Associated Vascular Microthrombotic Disease, and Proposed Therapeutic Approach with Antimicrothrombotic Therapy.
Chang JC
Vasc Health Risk Manag; 2021; 17():273-298. PubMed ID: 34103921
[TBL] [Abstract][Full Text] [Related]
17. Mathematical Modeling of Severe Acute Respiratory Syndrome Coronavirus 2 Infection Network with Cytokine Storm, Oxidative Stress, Thrombosis, Insulin Resistance, and Nitric Oxide Pathways.
Sasidharakurup H; Kumar G; Nair B; Diwakar S
OMICS; 2021 Dec; 25(12):770-781. PubMed ID: 34807729
[TBL] [Abstract][Full Text] [Related]
18. COVID-19 and Thrombosis: Clinical Aspects.
Urano T; Yasumoto A; Yokoyama K; Horiuchi H; Morishita E; Suzuki Y
Curr Drug Targets; 2022; 23(17):1567-1572. PubMed ID: 36200150
[TBL] [Abstract][Full Text] [Related]
19. Venous Thrombosis and SARS-CoV-2.
Zdanyte M; Rath D; Gawaz M; Geisler T
Hamostaseologie; 2022 Aug; 42(4):240-247. PubMed ID: 34879422
[TBL] [Abstract][Full Text] [Related]
20. Preventing the development of severe COVID-19 by modifying immunothrombosis.
Morris G; Bortolasci CC; Puri BK; Olive L; Marx W; O'Neil A; Athan E; Carvalho A; Maes M; Walder K; Berk M
Life Sci; 2021 Jan; 264():118617. PubMed ID: 33096114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
